US-China Economic and Trade Agreement Phase 1 – Pharmaceutical related IP issues

June 16th, 2020 | 10 AM EST – 12 PM EST | Zoom Webinar

Event Agenda


Welcome remarks
Richard Glanton, Chairman of Board of directors of UCIPF


Overview of IP provisions of the recent Economic and Trade Agreement between U.S. and China phase 1

Mark Cohen, Lecturer in Law, Distinguished Senior Fellow, and Director at the University of California at Berkeley
Advisory Board, UCIPF


Supplemental Data filing in China and Patent Term Extension

    • Current practice for post filing data in China

Luke Zuo, Senior Partner, NTD Patent & Trademark Agency Limited

    • Current challenges for US Pharmaceutical companies for posting filing data issues in China

R. Craig Tucker, Senior Patent Counsel, Eli Lilly

    • What we expect that China implement the IP provisions of the Economic and Trade Agreement in the future for Post filing data
    • Patent Term Extension

Tom Hoxie, Managing Partner, Hoxie & Associates LLC.




Closing remarks
Demi Wang, Founder, Chief Executive Officer


Thank you to our supporters!


Richard H. Glanton

Mark Cohen

Larry (Lubing) Lian

Luke Zuo, M.D.

R. Craig Tucker

Thomas Hoxie

Demi Wang – Founder, Chief Executive Officer

June 16th, 2020

10 AM EST – 12 PM EST

Zoom Webinar

Reserve your seat

The numbers below include tickets for this event already in your cart. Clicking "Get Tickets" will allow you to edit any existing attendee information as well as change ticket quantities.
Pharmaceutical Lawyers
$ 250.00
Corporate Lawyers/Scholars/Students
$ 150.00